Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Detalles Bibliográficos
Autores principales: Vanassche, T., Engelen, M. M., Van Thillo, Q., Wauters, J., Gunst, J., Wouters, C., Vandenbriele, C., Rex, S., Liesenborghs, L., Wilmer, A., Meersseman, P., Van den Berghe, G., Dauwe, D., Verbeke, G., Thomeer, M., Fivez, T., Mesotten, D., Ruttens, D., Heytens, L., Dapper, I., Tuyls, S., De Tavernier, B., Verhamme, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770739/
https://www.ncbi.nlm.nih.gov/pubmed/33375932
http://dx.doi.org/10.1186/s13063-020-04991-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770739/
https://www.ncbi.nlm.nih.gov/pubmed/33375932
http://dx.doi.org/10.1186/s13063-020-04991-y

Ejemplares similares